SAMe in liver disease allows patients to SEE and FEEL the improvements as early as 2 weeks

Liver disease is a significant global health problem affecting almost a quarter of people in industrialised countries. The most prevalent liver diseases are nonalcoholic fatty liver disease (NAFLD) and the more severe nonalcoholic steatohepatitis (NASH). NAFLD is now known as metabolic dysfunction-associated steatotic liver disease (MASLD) and NASH is now known as metabolic dysfunction-associated steatohepatitis (MASH). An important but often overlooked symptom of chronic liver disease is fatigue, which significantly impacts the quality of life of affected individuals.